The broad market has been improving significanlty. However,...

The broad market has been improving significanlty. However, Biota shares are trading as if the company is going into serious trouble. According to the company's announcements, things have been going well in side the company. How to explain that?

Maybe it is just because the management has chosen to merger with the failing dog company. Maybe the US market will punish the "dog" company even harder after the merger.

No deal since the announcement of the HRV Phase IIB trial result. NO further trials planned yet. How Can we expect the management to extract to extract value from the pipelines? Now, the only hope is Lani ROW as it is fully funded. I jsut hope they will not stuff up the Lani ROW rights and Marketing after Lani goes to the US market.


A hard lesson learnt from investing in BTA: Never invest in a opportunistic and lier management.


Just my thoughts.